VERIFIEDMint Markets·23 Oct 2026negative

SRF's persistent pain point hampers investors' confidence on earnings outlook

AI Summary

·SRF's management reiterated its 15-20% revenue growth guidance for the chemicals business.
·The company expects to deliver at the higher end of the revenue growth range in FY27.
·A persistent pain point is hampering investor confidence in the earnings outlook.